AHP, Acute hospitalisation phase; P&I; patient and insurer (combination); P&H, patient and hospital (combination); NHCS, National Health Care System; LOS, length of hospital stay; refers to acute hospitalization phase, and is only shown for studies where this information was explicitly provided; N/R, not reported; SAH, subarachnoid hemorrhage; ICH, intracerebral hemorrhage; IS, ischemic stroke; TIAs, transient ischemic attacks; DM, diabetes mellitus; CT, computed tomography LOS: for study #6, the LOS refers to the median, rather than the mean; Cost per Day: for study #6, the Cost per Day was based on the median, rather than the mean LOS; Currency: for #1, the total costs for the whole study period were transformed to US $, while the hospitalization costs were reported in ₩ 
OBJECTIVES
♦ To report on published costs of stroke over the past 5 years and to delineate the costing methodologies employed.
RESULTS
♦ In total, 78 articles were identified through the PubMeD Search (Figure 1 ). ♦ Thirty-four (21%) met the selection criteria on the basis of abstract review; 12 studies were excluded after full papers were retrieved. ♦ Twenty-two (22) were included in the analysis. Study Designs Employed ♦ The key characteristics of the final 22 articles reviewed are presented in Table 1 . ♦ Thirty-two percent (32%; n=7) of the studies were performed in Europe, 27% (n=6) were performed in Asia, 23% (n=5) in North America, 9% (n=2) in Latin America, and 9% (n=2) of the studies were performed in multiple countries. ♦ Cohort studies comprised 45% (n=10) of the sample, followed by database analyses (32%; n=7), register-based studies (9%; n=2), retrospective chart review studies (9%; n=2), and clinical trials (5%; n=1). ♦ In one study, it was indicated that the analysis was prevalence-based (#4); in 6 studies it was indicated that the analysis was incidence-based (#1, 3, 12, 15, 16, 19) .
Diagnostics and Population Characteristics
♦ Sample size ranged from 56 to 63,472 patients (Table 1 ). For most of the studies (55%, n=12), the sample size was below 1,000 patients. For the remaining studies (45%, n=10), the sample size was more than 3,000 patients, 7 studies of which (70%) were database analyses, 1 (10%) was a register-based study conducted in 62 hospitals in China, 1 (10%) was a prevalencebased study, and 1 (10%) was a retrospective cohort study performed for one of the two health-care clusters in Singapore. ♦ The most common tool used for stroke diagnosis and classification was the International Classification of Diseases (ICD) 9 and 10 (68.2%), followed by the World Health Organization (WHO) criteria (18.2%). ♦ The most common stroke types evaluated were Ischemic Stroke (IS) and Intracerebral Hemorrhage (ICH), at 95.5% and 68.2% of the cases, respectively. ♦ Stroke severity was mainly measured using the modified Rankin Scale (mRS), and the Health Institutes for Health Stroke Scale (NIHSS), both at 45.5% of the cases. ♦ Of the 13 studies that explicitly mentioned the incidence of stroke, 7 studies included recurrent strokes in addition to first-ever strokes.
Economic Findings
♦ The resource utilization data (excluding the database studies) were collected from medical records (80%; n=12), or from interviews (20%; n=3). ♦ The unit costs were primarily derived from national listings (tariffs) (45%; n=10), hospital accounting files (14%; n=3), Diagnostic Related Groups (14%, n=3), database analyses (9%, n=2), cost-to-charge ratios (9%, n=2), health insurance claims database (5%, n=1), or both national listings and hospital accounting files (5%, n=1). ♦ Cost categories measured included:
♦ Pre-admission costs: transportations, medications, diagnostic investigations, initial hospitalization in other (local general) hospitals. ♦ Acute hospitalization phase; direct and indirect medical and non-medical costs: emergency services, laboratory and radiological examinations, diagnostic investigations, surgical procedures, intensive care procedures, medications and pharmacy costs, physician services, rehabilitation, physiotherapy and speech therapy, supportive nursing care/ paid caregiver time, room charges (emergency department, general ward, intensive care units), overhead costs (bed, meals, cleaning, heating), patient lost productivity, unpaid caregiver time. ♦ Post-acute hospitalization phase: primary health care, home care, accommodation, municipality, medical/assistive devices (e.g., temperature set), changes to residence, companion, transports, patient lost productivity, unpaid caregiver time, cost of re-admittance to the hospital ♦ Total (hospitalization) costs incurred ♦ The majority of the studies concentrated on the acute hospitalization phase (59%), while in 9 studies, the patients were followed after their discharge between 3 (#21) months and up to 3 years (#1), with 7 studies performing a follow-up of 1 year. ♦ In the majority of the studies, the economic analysis employed a hospital perspective (64%, n=14). In two studies (9%) the economic analysis was employed a societal perspective ( Figure 2 ). ♦ Length of in-patient hospital stay (in the 17 studies reported), ranged between 8 and 38 days. ♦ The detailed results, and the stratified costs reported within each study, as well as the calculated costs (after transformation of local currencies to 2014 US $) are presented in Table 2 . ♦ In total 11 studies (50%) reported costs in local currencies, and 11 (50%) studies reported costs after transforming local currencies to either US $ or €. Of these 11 studies, in 6 (55%) the transformation was based on Purchasing Power Parity; for the remaining 5 (45%) the transformation algorithm was not specified. ♦ The cost per patient ranged from US $983 to US $71,542, and the costs per day ranged from US $67 to US $8,259; reflecting the heterogeneous cost variables described. ♦ In case the study measured costs for stroke treatment outside the acute hospitalization period, the most relevant cost component provided was used for the purposes of the present analysis: ♦ In studies #1 and #12, the results reflected the 1-year inpatient costs for stroke; in study #2, the costs of hospitalisation within 7 days of index stroke or TIA; in study #3 and #21, the costs of hospitalization to three months post-stroke; and in studies #4, #8, #13, #19, and #22 the index hospitalization care costs.
Statistical Analyses
♦ In the 14 studies that performed a regression analysis, in order to identify potential predictors for cost, it was found that the main predictors were: ♦ Length of hospital stay, ♦ Demographic characteristics (gender, age, race, marital status, household income) ♦ First stroke, history of previous strokes, and recurrent strokes (in case of follow up) ♦ Type of stroke and aetiology ♦ Stroke severity at admission and disability at discharge ♦ Medical history and risk factors ♦ Death during hospitalization and discharge destination ♦ Hospital characteristics (location and type) ♦ Performance of special procedures and high-priced drug (thrombolysis) ♦ Medical insurance status ♦ Presence of in-hospital complications ♦ Stay in increased care unit
